Join
Live feed
·
INSIDERFilingvia Quantisnow
MAIA Biotechnology Inc. logo

Amendment: Chief Executive Officer Vitoc Vlad bought $10,144 worth of shares (10,500 units at $0.97), increasing direct ownership by 1% to 831,421 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MAIA (MAIA Biotechnology Inc.) and more on Quantisnow.